Dose‐sparing and safety‐enhancing effects of an IGF ‐I‐based dosing regimen in short children treated with growth hormone in a 2‐year randomized controlled trial: therapeutic and pharmacoeconomic considerations-Reference-Cited by-同舟云学术

Dose‐sparing and safety‐enhancing effects of an IGF ‐I‐based dosing regimen in short children treated with growth hormone in a 2‐year randomized controlled trial: therapeutic and pharmacoeconomic considerations

Published:2014-02-07 Issue:1 Volume:81 Page:71-76
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Cohen Pinchas¹,Weng Wayne²,Rogol Alan D.³,Rosenfeld Ron G.⁴,Kappelgaard Anne‐Marie⁵,Germak John²

Affiliation:

1. University of Southern California Los Angeles CAUSA

2. Novo Nordisk Inc Plainsboro NJUSA

3. University of Virginia Charlottesville VAUSA

4. Oregon Health and Science University Portland OR USA

5. Novo Nordisk A/S Søborg Denmark

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.12408

Reference34 articles.

1. Insulin Growth Factor-Based Dosing of Growth Hormone Therapy in Children: A Randomized, Controlled Study

2. Variable Degree of Growth Hormone (GH) and Insulin-Like Growth Factor (IGF) Sensitivity in Children with Idiopathic Short Stature Compared with GH-Deficient Patients: Evidence from an IGF-Based Dosing Study of Short Children

3. Growth Hormone (GH) Dosing during Catch-Up Growth Guided by Individual Responsiveness Decreases Growth Response Variability in Prepubertal Children with GH Deficiency or Idiopathic Short Stature

4. Estimated Cost-effectiveness of Growth Hormone Therapy for Idiopathic Short Stature

5. Long-Term Safety of Recombinant Human Growth Hormone in Children

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical profiles and molecular genetic analyses of 98 Chinese children with short statures;Frontiers in Genetics;2024-06-12

2. Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic study;PeerJ;2023-10-09

3. Model-Based Analysis of IGF-I Response, Dosing, and Monitoring for Once-Weekly Somapacitan in Children With GH Deficiency;Journal of the Endocrine Society;2023-09-11

4. Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency;Frontiers in Endocrinology;2021-09-01

5. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment;Journal of Pediatric Endocrinology and Metabolism;2021-07-22